Biotecnikaglobal

ONE STOP SITE FOR ALL YOUR BIOTECHNOLOGY NEEDS

You are here: IMMUNOTECHNOLOGY> Tumor Immunology > TUMOR ANTIGENS

TUMOR ANTIGENS
Two types of tumor antigens have been identified on tumor cells:
  1. Tumor specific transplantation antigens ( TSTAs)
  2. Tumor associated transplantation antigens (TATAs)

Tumor specific transplantation antigens are unique to tumor cells and do not occur on normal cells in the body. They may result from mutations in tumor cells that generate altered cellular proteins; cytosolic processing of these proteins are presented with class I MHC molecules inducing a cell mediated response by tumor specific CTLs.

Tumor associated transplantation antigens (TATAs) are not unique to tumor cells; may be proteins that are expressed on normal cells during fetal development when the immune system in immature. Reactivation of the embryonic genes that encode these proteins in tumor cells results in their expression on the fully differentiated tumor cells.

 

These TATAs can help diagnose various tumors hence used as TUMOR MARKERS. These are substances that can be found in the body( usually in blood & urine) when cancer is present. They are generally detected by combining blood or urine with man made antibodies designed to react with them.

The first modern tumor marker used to detect cancer was HUMAN CHORIONIC GONADOTROPIN (hCG).A high level of hCG in the blood after pregnancy indicates cancer of the placenta called Gestational trophoblastic disease (GTD).The second tumor marker used was CARCINO EMBRYONIC ANTIGEN (CEA), found in the blood of patients suffering with colon cancer.

COMMONLY USED TUMOR MARKERS
  CARCINO EMBRYONIC ANTIGEN:
  • A protein polysaccharide complex
  • present in colon carcinomas & in normal fetal intestine, pancreas and liver.
  • elevated levels are also found in chain smokers and in patients with cirrhosis
  • Monitoring CEA level may be useful fro detecting cancer recurrence

ALPHA FETOPROTEIN

  • A normal product of fetal liver cells.
  • Elevated levels are present in sera of patients with primary hepatoma, yolk sac neoplasm, ovarian or testicular embryonal carcinoma

BETA SUBUNIT OF hCG

  • Found in women with gestational trophoblastic neoplasia & in about 2/3rd of men with testicular/ embryonal carcinoma/chorio caranoma.
PROSTATE SPECIFIC ANTIGEN
  • A glycoprotein located in ductal epithelial cells of the prostate gland
  • Elevated levels are present in 90% of patients with advanced prostate cancer
  • Can be used to monitor the recurrence of the prostate cancer.

CA125

  • It is clinically useful for diagnosing & monitoring therapy for ovarian cancer

BETA 2 MICROGLOBULIN

  • this is often elevated in multiple myelloma & in some lymphomas

CA 19-9

  • used to detect colorectal cancer & pancreatic cancer
  • primarily used to judge the response to treatment in patients with advanced pancreatic cancers
  • Also found elevated in other cancers of bile duct.
 

CA 15-3

  • Elevated in 50-80% patients suffering with metastatic breast cancers
  • primarily used to study the response to therapy

CHROMOGRANIN A

  • Used as marker for neuro-endocrine tumors.
  • abnormal levels can be seen in metastatic cancer patients of lung & prostate

THYROGLOBULIN

  • Produced by thyroid
  • primarily used after complete thyroidectomy to detect recurrent thyroid cancer & to follow the response to treatment in metastatic thyroid cancer

TA 90

  • it is a highly immunogenic subunit of urinary tumor associated antigen
  • present in 70 % of melanomas, soft tissue sarcomas & carcinomas of the breast colon & lung.
  search
 

EXAM ALERT

BROWSE BY SUBJECTS

 

 

 

 

 

 

 

HOME BIOTECNIKA BASICS BIOTECH COMPANIES PROJECTS ASK QUERIES

ABOUT US

BIOTECH JOBS

BIOTECHNOLOGY  COLLEGES

DOWNLOADS

sitemap

Copyright 2005 BIOTECNIKA global. All Rights Reserved. disclaimerfree hit counter